Autopsy report · NCT01294007

Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)

“Product no longer on the market”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 9 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 8 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Alphatec Spine, Inc.

Sponsor type

Industry

Conditions

Lumbar Degenerative Disc Disease

Interventions

PureGen Osteoprogenitor Cell Allograft; Autograft bone

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
  “Product is no longer being manufactured and marketed.” (77% match in meaning)
• The Study for Evaluate of Satety and Dfficacy of Hemostatic Device
  “The company stopped manufacturing the product” (65% match in meaning)
• Treatment of Hemorrhagic Fever With Ribavirin
  “Product expired, new lots not available” (64% match in meaning)
• Stomaplasty Ring (KoringTM) for Prevention of Parastomal Hernia
  “The device used was removed from the market” (61% match in meaning)
• Care China-Diabetes
  “the product was delisted.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.